Once free, drug for rare disease now being sold for $375K a year
02:01
Link copied
Thanks to a law designed to encourage drug development for rare diseases, Catalyst Pharmaceuticals can now sell the treatment exclusively for seven years -- and has set the price for it at $375,000 on average, when it used to be given to patients for free by a smaller drug company.Feb. 7, 2019
UP NEXT
Wildfires in Canada impact air quality in U.S. cities
01:26
House to vote on debt ceiling bill tonight
02:01
Plane mechanic helps keep dream alive for 4-year-old who died of cancer
02:10
Dramatic car flip caught on camera
01:19
NASA and Pentagon officials present UFO preliminary findings
01:30
Government proposes rule to require automatic emergency braking systems in new cars